BMC Nephrol. 2012 Aug 1;13:74. doi: 10.1186/1471-2369-13-74.
Systematic reviews comparing the effectiveness of strategies to prevent, detect, and treat chronic kidney disease are needed to inform patient care. We engaged stakeholders in the chronic kidney disease community to prioritize topics for future comparative effectiveness research systematic reviews. We developed a preliminary list of suggested topics and stakeholders refined and ranked topics based on their importance. Among 46 topics identified, stakeholders nominated 18 as 'high' priority. Most pertained to strategies to slow disease progression, including: (a) treat proteinuria, (b) improve access to care, (c) treat hypertension, (d) use health information technology, and (e) implement dietary strategies. Most (15 of 18) topics had been previously studied with two or more randomized controlled trials, indicating feasibility of rigorous systematic reviews. Chronic kidney disease topics rated by stakeholders as 'high priority' are varied in scope and may lead to quality systematic reviews impacting practice and policy.
需要进行系统评价,比较预防、检测和治疗慢性肾脏病的策略,以为患者治疗提供信息。我们让慢性肾脏病领域的利益相关者参与进来,为未来的比较效果研究系统评价确定优先事项。我们制定了一份建议主题的初步清单,利益相关者根据重要性对主题进行了细化和排名。在所确定的 46 个主题中,利益相关者将 18 个主题评为“高”优先级。其中大多数涉及减缓疾病进展的策略,包括:(a)治疗蛋白尿,(b)改善获得医疗的机会,(c)治疗高血压,(d)使用健康信息技术,以及(e)实施饮食策略。18 个高优先级主题中的大多数(15 个)之前已经用两项或更多项随机对照试验进行了研究,这表明进行严格的系统评价是可行的。利益相关者评为“高优先级”的慢性肾脏病主题范围广泛,可能会产生影响实践和政策的高质量系统评价。